| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 10.120 | 16.291 | 15.716 | 26.204 | 38.151 | 39.907 | 73.865 |
| Total Income - EUR | - | - | - | 10.120 | 16.291 | 15.716 | 26.204 | 38.151 | 39.927 | 73.875 |
| Total Expenses - EUR | - | - | - | 416 | 843 | 3.098 | 3.979 | 9.075 | 16.328 | 18.204 |
| Gross Profit/Loss - EUR | - | - | - | 9.705 | 15.448 | 12.618 | 22.226 | 29.076 | 23.600 | 55.672 |
| Net Profit/Loss - EUR | - | - | - | 9.401 | 14.959 | 12.180 | 21.440 | 28.150 | 23.200 | 53.456 |
| Employees | - | - | - | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Volod Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 0 | 0 | 22.935 | 16.579 | 10.121 | 3.932 |
| Current Assets | - | - | - | 9.946 | 24.906 | 36.637 | 30.967 | 28.106 | 18.409 | 53.089 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 1.138 | 1.372 | 0 | 2.077 | 22.469 | 1.713 | 1.704 |
| Cash | - | - | - | 8.808 | 23.534 | 36.637 | 28.890 | 5.638 | 16.695 | 51.385 |
| Shareholders Funds | - | - | - | 9.444 | 24.220 | 35.942 | 53.552 | 28.198 | 27.391 | 53.504 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 502 | 686 | 696 | 351 | 16.487 | 1.139 | 3.517 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Volod Med S.r.l.